Study on OMT-28 in Maintenance of Sinus Rhythm in Patients With Persistent Atrial Fibrillation (AF)
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 136 participants.
Also called NCT03906799
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 136 participants
- Sponsor
- Omeicos Therapeutics GmbH
- Registry
-
NCT03906799
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Bulgaria, Czechia, Hungary, Ukraine
- Registry status
- Completed
Technical summary
Registry record NCT03906799. Randomized; triple masking; primary purpose treatment. Start 2019-03-19 (actual); primary completion 2019-11-20 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study on OMT-28 in Maintenance of Sinus Rhythm in Patients With Persistent Atrial Fibrillation (AF)
- Acronym
- PROMISE-AF
- Condition
- Atrial Fibrillation
- Intervention (Drug)
- OMT-28
- Intervention (Drug)
- Placebo
- Lead sponsor
- Omeicos Therapeutics GmbH
Record details
- Record id
cardio:ct-nct03906799- Content hash
cec0bc0cc936137049d3e0f53d1d8ba82261d97d87294c922392a8ede0f3946a